HLA-C and type 1 diabetes mellitus: For rheumatoid arthritis and Type 1 diabetes, we show improvements in predictive accuracy from assigning distinct random effects to SNPs within and outside the major histocompatibility complex (MHC), because for these two traits, MHC SNPs tend to have larger effects.